HealthEquity, Inc. (NASDAQ:HQY) Shares Bought by Clearbridge Investments LLC

Clearbridge Investments LLC grew its position in HealthEquity, Inc. (NASDAQ:HQY) by 1.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,377,204 shares of the company’s stock after purchasing an additional 43,491 shares during the quarter. Clearbridge Investments LLC owned about 2.73% of HealthEquity worth $204,915,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in HQY. Hsbc Holdings PLC acquired a new position in shares of HealthEquity during the fourth quarter valued at about $4,490,000. Parallel Advisors LLC increased its stake in HealthEquity by 255.5% during the 4th quarter. Parallel Advisors LLC now owns 679 shares of the company’s stock valued at $45,000 after purchasing an additional 488 shares in the last quarter. TFO Wealth Partners LLC raised its holdings in shares of HealthEquity by 30,025.0% in the fourth quarter. TFO Wealth Partners LLC now owns 1,205 shares of the company’s stock worth $80,000 after buying an additional 1,201 shares during the last quarter. Campbell & CO Investment Adviser LLC lifted its stake in shares of HealthEquity by 3.2% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 8,195 shares of the company’s stock worth $543,000 after buying an additional 254 shares during the period. Finally, Forest Hill Capital LLC purchased a new stake in shares of HealthEquity during the fourth quarter valued at $2,021,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $80.27 on Wednesday. The stock has a market capitalization of $6.98 billion, a price-to-earnings ratio of 87.25, a price-to-earnings-growth ratio of 1.25 and a beta of 0.52. HealthEquity, Inc. has a 52 week low of $61.81 and a 52 week high of $88.26. The firm has a 50-day simple moving average of $76.42 and a 200-day simple moving average of $79.21. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The business had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. On average, equities analysts predict that HealthEquity, Inc. will post 2.25 earnings per share for the current fiscal year.

Analysts Set New Price Targets

HQY has been the subject of a number of research reports. Raymond James lifted their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. Barrington Research reiterated an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research report on Friday, September 20th. JMP Securities reissued a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. Wells Fargo & Company upped their price objective on shares of HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a report on Thursday, June 20th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $92.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and an average price target of $103.83.

Insider Buying and Selling at HealthEquity

In other news, Director Frank Corvino sold 7,705 shares of the business’s stock in a transaction dated Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the transaction, the director now owns 6,070 shares of the company’s stock, valued at approximately $497,072.30. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, Director Frank Corvino sold 7,705 shares of the firm’s stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the completion of the sale, the director now owns 6,070 shares in the company, valued at approximately $497,072.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the transaction, the insider now owns 89,769 shares in the company, valued at $7,168,952.34. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.